Bank of Montreal’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,200
Closed -$174K 5139
2019
Q3
$174K Buy
+9,200
New +$105K ﹤0.01% 2991

Bank of Montreal's ALDR Position: Q4 2019 in Review

Bank of Montreal sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 8,932 shares — an estimated $169K sold.

Bank of Montreal first reported a position in ALDR in Q3 2015 and held it in 17 quarters. The position peaked at $422K in Q4 2017. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Bank of Montreal reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Bank of Montreal sold 8,932 Alder Biopharmaceuticals shares in Q4 2019, an estimated $169K.
  • Bank of Montreal first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 17 quarters.
  • Bank of Montreal's Alder Biopharmaceuticals position peaked at $422K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.